硒与血液透析患者促红细胞生成素反应相关
该横断面研究检测173例日本血液透析患者的血清硒水平,分析其与促红细胞生成素抵抗指数(ERI)的关系。结果发现血清硒与ERI显著负相关,低血清硒(<10.5 μg/dl)与铁缺乏均显著影响ESA反应;校正混杂因素后,低硒与ESA低反应性的关联持续存在。
要点
- 50%的血液透析患者血清硒水平低于人群参考值。
- 血清硒与ERI显著负相关,但与转铁蛋白饱和度或铁蛋白无显著相关。
- 低血清硒(<10.5 μg/dl)和铁缺乏均显著影响ESA反应。
核心结论
- 在日本血液透析患者中,血清硒水平与ESA反应相关,且独立于铁状态预测ESA抵抗。
- 这些数据为检验补硒是否减少ESA需求量提供了可能性。
研究设计与样本
- 横断面研究,纳入173例血液透析患者,检测血清硒水平并分析其与ESA抵抗指数(ERI)的关联。
主要发现
- 50%的研究参与者血清硒水平低于人群参考值。
- 血清硒水平与ERI显著负相关,但与转铁蛋白饱和度或铁蛋白水平无显著相关。
- 多因素回归分析证实硒水平与ESA低反应性独立相关,校正铁状态、女性、透析龄等因素后β=-0.11,P<0.001。
- 按硒水平和铁状态分组,低血清硒(<10.5 μg/dl)和铁缺乏均显著影响ESA反应。
- 按ERI四分位分组时,各组间血清硒水平显著不同;校正混杂变量后,低血清硒与ESA低反应性的关联持续存在。
关键数值与推荐
- ESA反应性以ESA抵抗指数(ERI)定义。
- 低血清硒定义为<10.5 μg/dl。
- 多因素回归中硒与ESA低反应性独立相关(β=-0.11,P<0.001)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Impaired response to erythropoiesis-stimulating agents (ESAs) is associated with increased mortality in patients with end-stage kidney disease. However, the underlying mechanisms are not fully elucidated. Accumulating data reveal that selenium (Se), a trace element, plays a key role in stress erythropoiesis and erythrocyte homeostasis. We evaluated the relationship between serum Se levels and the response to ESAs in hemodialysis patients. METHODS: In this cross-sectional study, we determined serum Se levels in 173 hemodialysis patients. We analyzed the association of serum Se with ESA responsiveness, as defined by ESA resistance index. RESULTS: Of the study participants, 50% had lower Se levels than the population-based reference values. We found that serum Se levels were significantly and inversely correlated with erythropoiesis resistance index (ERI) but not transferrin saturation (TSAT) or ferritin levels. Multiple regression analyses confirmed the association between Se levels and ESA hyporesponsiveness, independently of other known factors, such as iron status, being female, and dialysis vintage (β = -0.11, P < 0.001). When patients were divided according to Se levels and iron status, both low serum Se (<10.5 μg/dl) and iron deficiency significantly affected the response to ESA. Conversely, serum Se levels were significantly different among groups when patients were divided according to ERI quartiles. The association of low serum Se with ESA hyporesponsiveness persisted after adjustment of confounding variables. CONCLUSION: Serum Se levels are associated with the response to ESAs and can predict ESA resistance independently of iron status in Japanese hemodialysis patients. These data open the possibility to test whether Se supplementation reduces ESA demand.
引用
- Yasukawa M, Arai S, Nagura M, et al. Selenium Associates With Response to Erythropoiesis-Stimulating Agents in Hemodialysis Patients. Kidney Int Rep. 2022. PMID: 35812286. doi:10.1016/j.ekir.2022.04.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。